Market Size, Growth & Valuation (2025-30)

Cell & Gene Therapy Drug Delivery Devices Market size was valued at around USD 1.27 billion in 2024 and is projected to reach USD 2.32 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.53% during the forecast period, i.e., 2025-30.

View Full Report - https://www.marknteladvisors.com/research-library/cell-gene-therapy-drug-delivery-devices-market.html

Cell & Gene Therapy Drug Delivery Devices Market Structure – Segmentation & Geography

By Product Type

• Sub-retinal Injection Cannula
• Extension Tube
• Intravenous Catheter
• Sterile Insulin Syringe
  • Size 1.0 ML, 31-Gauge Needle
  • Size 0.5 ML, 22-Gauge Needle
• Pre-Filled Syringe
  • Size 1.0 ML, 22-26 Gauge Needle
  • Size 4.0 ML, 22-26 Gauge Needle
• Infusion Bags
  • Infusion Bags (Size 10 ML to 50 ML)
  • Infusion Bags (Size 68 ML)
  • Infusion Bags (Size 60 ML)
  • Infusion Bags (Size Up to 65 ML)

By Technology

• Microchip Technology
• Nano-Technology
• Lipid Nanoparticles

By Commercialized Drugs

• Luxturna
• Kymriah
• Yescarta
• Zolgensma
• Provenge
• Strimvelis

Luxturna & Yescarta overpowered the Global Cell & Gene Therapy Drug Delivery Devices Market in 2024.

By End-User

• Pharmaceuticals & Biotechnology Company
• Academic & Research Institute
• Hospitals & Clinics

By Region

• North America
• South America
• Europe
• Middle East & Africa
• Asia-Pacific.

North America attained majority of revenue share and is anticipated to prevail the same trend in the forecast period.

Key Growth Trends (2025-2030)

Shift Toward Personalized and Targeted Therapies – The most significant trend shaping the market is the growing shift toward personalized and targeted therapies. As biotechnology and genetic engineering advance, there is a heightened focus on developing delivery systems that can precisely administer cell and gene therapies tailored to individual patient profiles. This trend is supported by increased investment in research and development, as well as the creation of novel delivery platforms that enhance treatment efficacy and safety.

Download Free Sample PDF - https://www.marknteladvisors.com/query/request-sample/cell-gene-therapy-drug-delivery-devices-market.html

Research Methodology

MarkNtel Advisors employs a thorough and iterative research methodology to enhance accuracy in market estimates. Our process combines bottom-up and top-down approaches, focusing on data triangulation for validation. It includes defining research objectives, selecting representative samples, and collecting data through surveys and interviews. Post-collection, we analyze and validate the data using statistical tools, ensuring reliability. Finally, we forecast market trends through predictive modeling, compiling our insights into detailed reports with charts and strategic recommendations for informed decision-making.

Competitive Analysis Framework

The Cell & Gene Therapy Drug Delivery Devices industry is moderately fragmented, with key players focusing on technological advancements and strategic partnerships. A detailed competitive analysis helps businesses benchmark against industry leaders and identify growth opportunities.

Leading Cell & Gene Therapy Drug Delivery Devices Companies are:

• Amgen Inc.
• Bausch & Lomb Incorporated
• Becton, Dickinson and Company
• Bluebird bio Inc.
• Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.)
• Dendreon Pharmaceuticals LLC
• Helixmith Co. Ltd (ViroMed Co., Ltd)
• Human Stem Cells Institute
• Kite Pharma Inc.
• Kolon TissueGene, Inc.
• Novartis AG
• Orchard Therapeutics plc.
• Pfizer Inc.
• Renova Therapeutics
• Spark Therapeutics Inc.
• uniQure N.V.
• Vericel Corporation.

📊 Looking for a Customized Market Research Report? Visit – https://www.marknteladvisors.com/query/request-customization/cell-gene-therapy-drug-delivery-devices-market.html

(Need global, regional or country-specific data? We can tailor research to your exact requirements)

Key Questions Answered in This Report:

1. What is the current market size of Cell & Gene Therapy Drug Delivery Devices, and what growth rate is projected by 2030?
2. Which key trends are driving Cell & Gene Therapy Drug Delivery Devices market expansion in the next five years?
3. How does market segmentation impact industry dynamics?
4. Which geographic regions offer the highest growth potential?
5. What are the primary challenges hindering Cell & Gene Therapy Drug Delivery Devices industry growth?
6. How do regulatory policies influence market development?
7. What are the latest technological advancements impacting the sector?
8. Who are the leading Cell & Gene Therapy Drug Delivery Devices companies, and what are their market shares?
9. What strategies are top competitors adopting to maintain dominance?
10. What are the emerging niche segments with high growth potential?
11. How do macroeconomic factors affect market performance?
12. What are the investment opportunities for new entrants?
13. How does pricing strategy vary across different market segments?
14. What are the future innovation trends expected in this industry?

Other Report:

• https://medium.com/@amitkumarmarkntel/egypt-diesel-generator-market-size-forecast-2025-2030-trends-and-growth-insights-2c7b8db13555?postPublishedType=initial
• https://uberant.com/article/2125787-north-africa-air-conditioner-market-analysis-20252030-size-share-future-outlook/
• https://globalriskcommunity.com/profiles/blogs/india-automotive-lubricants-market-analysis-2025-2030-size-share-

About Us – MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact:

MarkNtel Advisors

Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

Email: sales@marknteladvisors.com

Visit our Website: https://www.marknteladvisors.com